Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells

Breast Cancer Research and Treatment

Volumn 76, Issue 1, 2002, Pages 1-10

  Bodinet, Cornelia ^a   Freudenstein, Johannes ^a  

^a Schaper & Brummer GmbH & Co KG   (Germany)

Author keywords

Black cohosh; Cimicifuga racemosa; Hormone replacement therapy; In vitro; MCF 7; Menopause; Phytoestrogens; Proliferation assay; SERM

Indexed keywords

2 PROPANOL; ANTIESTROGEN; CIMICIFUGA RACEMOSA EXTRACT; ESTROGEN; TAMOXIFEN;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DILUTION; DRUG EFFECT; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MENOPAUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL DIVISION; CIMICIFUGA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; PLANT EXTRACTS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0036838048     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020241509382     Document Type: Article

References (28)

1. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059, 1997
2. Beuscher N: Cimicifuga racemosa L.: Die Traubensilberkerze. Z Phytother 16: 301-310, 1995
3. Murray MT: Remifemin: answers to some common questions. Am J Nat Med 4: 3-5, 1997
4. Jarry H, Harnischfeger G, Düker EM: Studies on the endocrine effects of the contents of Cimicifuga racemosa: 2. In vitro binding of compounds to estrogen receptors. Planta Med 51: 316-319, 1985
5. Mc Coy J, Kelly W: Survey of Cimicifuga racemosa for phytoestrogenic flavonoids. In: Book of Abstracts. 212th ACS National Meeting, Orlando, FL, August 25-29, 1996. American Chemical Society, Washington, DC, 1996, Abstract 082
6. Struck D, Tegtmeier M, Harnischfeger G: Flavones in extracts of Cimicifuga racemosa. Planta Med 63: 289-290, 1997
7. Kruse SO, Löhning A, Pauli GF, Winterhoff H, Nahrstedt A: Fukiic and piscidic acid esters from the rhizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukinolic acid. Planta Med 65: 763-764, 1999
8. Schwarte AE: Wirkspektrum Ausgewählter Flavonoide Auf Die Humane Brustkrebszellinie MCF-7. Universität Witten-Herdecke, Witten, Germany, 1994
9. Jones PA, Baker VA, Irwin A, Earl LK: Modulation of MCF-7 cell proliferative response by manipulation of assay conditions. Toxicol In Vitro 11: 769-773, 1997
10. Diel P, Smolnikar K, Michna H: In vitro test systems for the evaluation of the estrogen activity of natural products. Planta Med 65: 197-203, 1999
11. Boblitz N, Liske E, Wüstenberg P: Black cohosh. DAZ 24: 107-114, 2000
12. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, ven der Burg B, Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139: 4252-4263, 1998
13. Jarry H, Harnischfeger G: Studies on the endocrine effects of the contents of Cimicifuga racemosa: 4. Influence on the serum concentration of pituitary hormones in ovariectomized rats. Planta Med 51: 46-49, 1985
14. Düker EM, Kopanski L, Jarry H, Wuttke W: Effects of extracts from CR on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 57: 420-424, 1991
15. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K: Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas 25: 149-153, 1996
16. Neßelhut T, Schellhase T, Dietrich C: Untersuchungen zur proliferativen Potenz von Phytopharmaka mit östrogenähnlicher Wirkung bei Mammakarzinomzellen. Arch Gynecol Obstet 254: 817-818, 1993
17. Zava DT, Dollbaum CM, Blen M: Estrogen and progestin bio-activity of foods, herbs, and spices. Proc Soc Exp Biol Med 217: 369-378, 1998
18. Dixon-Shanies D, Shaikh N: Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Onc Rep 6: 1383-1387, 1999
19. Jarry H, Leonhardt S, Düls C, Popp M, Christoffel V, Spengler B, Theiling K, Wuttke W: Organ-specific effects of Cimicifuga racemosa on brain and uterus. 23rd International LOF-Symposium on Phyto-Oestrogens, Universitet Gent, Gent, Belgium, January 15, 1999, Gesellschaft för Arzneipflanzenforschung, Wädenswill, Switzerland, 1999, Poster
20. Wuttke W, Jarry H, Heiden I, Westphalen S, Seidlová-Wuttke D, Christoffel V: Selective estrogen receptor modulator (SERM) activity of the Cimicifuga racemosa extract BNO 1055: pharmacology and mechanisms of action. Phytomedicine 7(Suppl II): 2, 2000
21. Li JX, Kadota S, Li HY, Miyahara T, Wu YW, Seto H, Namba T: Effects of Cimicifuga rhizoma on serum calcium and phosphate levels in low calcium dietary rats and on bone mineral density in ovariectomized rats. Phytomedicine 3(4): 379-385, 1996/1997
22. Nißlein T, Freudenstein J: Effects of black cohosh on urinary bone markers and femoral density in an OVX-rat model. Osteoporosis Int 11(Suppl 2): 191, 2000
23. Lieberman S: A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Womens Health Gend Based Med 7: 525-529, 1998
24. Freudenstein J, Dasenbrock C, Nißlein T: Lack of promotion of estrogen dependent mammary gland tumors in vivo by an isopropanolic black cohosh extract. Lecture presented at the Third International Congress on Phytomedicine, Munich, Germany, October 11-13, 2000. Phytomedicine 7(Suppl): 13, 2000
25. Haynes B, Dowsett M: Clinical pharmacology of selective estrogen receptor modulators. Drugs Aging 14: 323-336, 1999
26. Dayani N, McNaught R, Shenolikar S, Smith RG: Receptor interconversion model of hormone action: 2. Requirement of both kinase and phosphatase activities for conferring estrogen binding activity to the estrogen receptor. Biochemistry 29: 2691-2698, 1990
27. Shao ZM, Alpaugh ML, Fontana JA, Barsky SA: Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem 69: 44-54, 1998
28. Wang TY, Sathyamoorthy N, Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17: 271-275, 1996